Speaker illustration

Doctor Markus Riederer

Idorsia Pharmaceuticals Ltd., Allschwil (Switzerland)

Selatogrel, the reversible and specific P2Y12 receptor antagonist, does not interfere with haemostasis

Event: ESC Congress 2020

Topic: Thrombosis, Bleeding

Session: Role of Platelets, Inflammation and Endothelial Cells in Vascular Dysfunction


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb